WO2011000698A2 - Single-phase hair conditioner having an increased amount of silicone - Google Patents

Abstract

The invention relates to single-phase hair treatment agents comprising a cationic copolymer and an increased content of silicone, and to the use of said agents for treating hair.

Description

"Single phase conditioner with increased silicone content"

The invention relates to single-phase hair treatment compositions comprising a cationic copolymer and an increased content of silicones and to the use of these hair-treatment compositions. Not least due to the heavy use of hair, for example by dyeing or perming, as well as by the cleaning of the hair with shampoos and by environmental pollution, the importance of care products with the longest possible effect increases.

 However, the known active ingredients can not cover all needs sufficiently. There is therefore still a need for active ingredients or combinations of active substances for cosmetic products with good care properties. In particular, when silicone oils are incorporated in hair cosmetic compositions as active ingredients, at least two- or multi-phase formulations are obtained when the content of silicone oils in larger quantities. These two-phase systems must be converted by the consumer by vigorous shaking into a stable only for a short time single-phase system before use. Even with proper use of these products then a good product performance on the hair is not guaranteed. Therefore, we are still looking for stable single-phase systems with an increased content of silicone oils.

 Surprisingly, however, it has now been found that certain cationic polymers, together with more than 5% by weight of silicone oils, lead to stable single-phase compositions.

 At the same time, the use of these combinations leads to surprisingly good properties of the treated hair, in particular to improved combing and improved elasticity as well as a significantly increased wash resistance dyed hair, and to a longer shelf life with a simultaneous better forming performance in Wellvorgängen such as water wave and perm. In particular, however, the gloss of the hair treated with it is significantly increased.

 These positive properties are obtained both in a typical rinse-off and in a leave-on application. However, the composition according to the invention is outstandingly suitable for spray application as a non-aerosol. In this case, an extremely uniform spray pattern is achieved compared to the usual two-phase products. As a result, the entire composition is distributed very evenly on the hair.

A first object of the present invention is therefore a composition for

Treatment of keratinic fibers containing

 a) a cationic copolymer consisting of a monomer of the formula (I) and a monomer of the formula (II) and

 b) at least 5.0% by weight of at least one silicone oil, and

c) a cosmetic carrier. Ingredients a), b) and c) are described in detail below. As far as below the active ingredient complex (A) is spoken, this statement refers to the ingredients contained in the inventive compositions a), b) and c).

 Hair treatment agents in the context of the present invention are, for example

Hair conditioners, hair sprays, hair conditioners, hair treatments, hair wraps, hair tonics,

Hair fixatives, hair dressings, hair styling preparations, hair lotions lotions, mousses,

Hair gels, hair waxes or combinations thereof. Preferred agents according to the invention are

Shampoos, conditioners or hair tonics.

 By combing is understood according to the invention both the combability of the wet fiber, as well as the combability of the dry fiber. As a measure of the combing used the combing work or the force used during the combing serves a

Fiber collective. The measurement parameters can be judged by the expert or sensory

Measuring devices are quantified.

 As a handle defines the tactility of a fiber collective, the expert sensory the

Parameter abundance and suppleness of the collective feels and evaluates.

 Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.

 According to the invention, O / W, W / O and W / O / W are particularly suitable as cosmetic carriers c).

Emulsions in the form of creams or gels or other preparations which are particularly suitable for use on the hair. The cosmetic carriers may in particular be aqueous or aqueous-alcoholic.

 An aqueous cosmetic carrier contains at least 50% by weight of water.

For the purposes of the present invention, aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C ₁ -C ₆ -alcohol, in particular methanol,

Ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, iso-pentanols, n-hexanol, isohexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or

1, 6-hexanediol to understand. The agents according to the invention may additionally contain further organic

Solvents, such as, for example, methoxybutanol, benzyl alcohol, ethyl diglycol or 1, 2

Propylene glycol, included. Preference is given to all water-soluble organic solvents.

As ingredient a) the agents according to the invention contain at least one cationic copolymer.

The cationic copolymer is in this case composed of the monomers of the formulas (1) and (2),

 (1) (2)

in which R1 to R9 independently of one another are hydrogen, C1-C4-alkyl, methyl, ethyl, propyl, isopropyl, butyl, isobutyl or tert-butyl and with the proviso that at least one of the radicals R6, R7, R8 or R9 C1-C4alkyl, n is an integer from 1 to 8 and A is a physiologically acceptable anion such as halide, fluoride, chloride, bromide, iodide, hydrogen sulfate or methosulfate. Preferably, R 1 is hydrogen or a methyl group, more preferably R 1 is a methyl group. Preferably, R2 is hydrogen or a C1-C4alkylgruppe, more preferably R2 is hydrogen. Preferably, R3, R4 and R5 are independently hydrogen or a C1-C4alkylgruppe, in particular a methyl group. More preferably, R3, R4 and R5 are the same and most preferably methyl. The number n is preferably integer from 1 to 7, more preferably from 1 to 5, most preferably 1, 2, 3 or 4 and most preferably 2. R6 is preferably hydrogen or methyl. R 7 is preferably hydrogen, methyl or ethyl, more preferably methyl. R 8 and R 9 are preferably identical and represent hydrogen, methyl or C 1 -C 4 -alkyl, particularly preferably hydrogen or methyl. Most preferably, the monomer of formula (2) is dimethylacrylamide. The copolymer according to the invention consists of 20 to 95% by weight of the monomer (1) and 5 to 50% by weight of the monomer (2). Preferably, the monomer (1) to 40 to 90 wt.% And the monomer (2) to 10 to 40 wt.% Contained.

Of course, the cationic copolymer of the invention may be further crosslinked. In this case, the crosslinking by the usual cross-linking agent such as allyl acrylamide, allyl methacrylamide, tetraallylammonium chloride or N, N ^'causes up to 500 ppm methylene bis-acrylamide in amounts.

Furthermore, according to the invention it is included that the cationic copolymer as a solution or suspension or dispersion in suitable cosmetic media, such as propylene glycol, glycerol, paraffin, isoparaffin, propylene glycols and esters of propylene glycol such as propylene glycol dicaprylates / dicaprate, or PPG-1 trideceth-6 and others may be present. According to the bevorzugtesten is the commercial product TINOVIS ^® CD Ciba.

 The cationic copolymer of the present invention is used in an amount of 0.1 to 10% by weight based on the entire composition. Preference is given to amounts of from 0.1 to 5% by weight, more preferably from 0.1 to 3.0% by weight.

 Ingredient b) of the compositions according to the invention is at least one silicone oil. The selection of the silicone oil is carried out from the silicone oils known in the art. The silicone oil is usually selected from the group of dimethicones, to which the cyclomethicones are also to be expected, and / or the group of amino-functional silicones and / or the group of dimethiconols.

 Although the dimethicone copolyols are to be expected among the silicone oils, it is preferred according to the invention to select no dimethicone copolyol.

 The dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched. Linear dimethicones can be represented by the following structural formula (Sil):

(SiR ¹ ₃ ) - O - (SiR ² ₂ - O -) _x - (SiR ¹ ₃ ) (Sil)

Branched dimethicones can be represented by the structural formula (SiH):

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ² to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably, R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R ¹ and R ^{2 are} methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -. Preferred as R ¹ and R ² are methyl, phenyl and C ² to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of Dimethicone lie between 1,000 D and 10000000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ⁰ C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps. The word "about" defines a deviation from the stated value following the word "about" which is customary in the art for technically manufactured products. By way of example, reference may be made here to the product "Dow Corning 200 with 6000 OcSt" or "Dow Corning 200 with 5 cSt".

The cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention. Here, cosmetic or dermatological preparations according to the invention are preferred which contain at least one silicone of the formula (Si-4)

in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.

 The dimethicones are present in the compositions according to the invention in amounts of from 0.1 to 25% by weight, preferably 0.1 to 20% by weight, particularly preferably 0.1 to 15.0% by weight and in particular 5.0 to 15.0 % By weight, based on the total composition.

Dimethiconols (Si8) form another group of silicones which are particularly preferred according to the invention. The dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched. Linear dimethiconols can be represented by the following structural formula (Si8-I):

(SiOHR ¹ ₂ ) - O - (SiR ² ₂ - O -) _x - (SiOHR ¹ ₂ ) (Si 8 - I)

 Branched dimethiconols can be represented by the structural formula (Si8 - II)

become:

The radicals R ¹ and R ² are each independently hydrogen, a methyl radical, a C ² to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical. Non-limiting examples of the groups represented by R ¹ and R ² include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; Preferably, R ¹ and R ^{2 is} an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R ¹ and R ^{2 are} methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CHz) ₃ CC (O) OCH ₂ CH ₂ -, -C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -. Preferred as R ¹ and R ² are methyl, phenyl and C ² to C 22 alkyl radicals. The C2 to C22 alkyl radicals are especially lauryl, stearyl and behenyl radicals prefers. The numbers x, y and z are integers and each run independently from 0 to 50,000. The molecular weights of the dimethiconols are between 1,000 D and 10000000 D. The viscosities are between 100 and 10,000,000 cPs measured at 25 ⁰ C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are from 1000 to 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.

 Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF Emulsion, Dow Corning 9546 Silicone Elastomer Blend (all aforementioned Dow Corning Corporation), Dub Gel Sl 1400 (Stearinerie Dubois FiIs), HVM 4852 Emulsion (Crompton Corporation), Jeesilc 6056 (Jeen Internationa l Corporation), Lubrasil, Lubrasil DS (both Guardian Laboratories), Nonychosine E, Nonychosine V (both exsymol), SanSurf Petrolatum-25, Satin Finish (both Collaborative Laboratories, Inc.), Silatex-D30 (Cosmetic Ingredient Resources), Silsoft 148, Silsoft E-50, Silsoft E-623 (all previously referred to Crompton Corporation), SM555, SM2725, SM2765, SM2785 (all aforementioned GE Silicones), Taylor T-SiI CD-1, Taylor TME-4050E (all Taylor Chemical Company), THV 148 (Crompton Corporation), Tixogel CYD-1429 (Sud-Chemie Performance Additives), Wacker-Belsil CM 1000, Wacker-Belsil CM 3092, Wacker-Belsil CM 5040, Wacker-Belsil DM 3096, Wacker-Belsil DM 3112 VP, Wacker-Belsil DM 8005 VP, Wacker-Belsil DM 60081 VP (all Wacker-Chemie GmbH mentioned above).

 The dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.1 to 20% by weight, preferably 0.1 to 15% by weight, more preferably 0.1 to 10.0% by weight and in particular 0.1 to 7.5% by weight of dimethiconol based on the total composition. Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may e.g. by the formula (Si-2)

M (R _a Q _b Si0 ₍₄ - _a - _b) , ₂ ) _x (R _c Si0 ₍₄ - _{c) / 2} ) _y M (Si-2)

Be described, taking in the above formula

R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6

 Carbon atoms,

Q is a polar radical of the general formula -R ¹ HZ,

 wherein

R ^{1 is} a divalent linking group bonded to hydrogen and the radical Z, composed of carbon and hydrogen atoms, Carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and

 Z is an organic, amino-functional group containing at least one amino-functional group;

a assumes values in the range of about 0 to about 2,

b takes values in the range of about 1 to about 3,

a + b is less than or equal to 3, and

c is a number in the range of about 1 to about 3, and

x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and

y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy ,

Non-limiting examples of the groups represented by R in formula (Si-2) include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, - CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, - OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CHz) ₃ CC (O) OCH ₂ CH ₂ -, -C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group. A possible formula for said Z is NH (CH ₂ ) _Z NH ₂ , where z is an integer greater than or equal to 1. Another possible formula for said Z is -NH (CH ₂ ) _Z (CH ₂ ) _zz NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl. Said Z is most preferably an -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for said Z is - N (CH ₂ ) _Z (CH ₂ ) _ZZ NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH ₂ CH ₂ CH ₂ NH ₂ CH ₂ CH ₂ NH ₂ .

In the formula (Si-2), α assumes values in the range of 0 to 2, b takes values in the range of 2 to 3, a + b is less than or equal to 3, and c is a number in the range of 1 to 3. The molar ratio of the R _a Q _b SiO _{(4 a a b) / 2} units to the R ₀ SiO _{(4 C) / 2} units in formula (Si-2) is in the range of about 1: From 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1: 15 to about 1: 20. If one or more of the above silicones are used Formula (Si-2), then the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

 Preferred cosmetic or dermatological preparations according to the invention contain an amino-functional silicone of the formula (Si-3)

R _'a G ₃ - _a -Si (OSiG _{2) n} - (OSiG _b R' _{2-b) m} -O-SiG ₃ - _a -R _'a (Si-3),

 where:

G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH ( CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -O-C (CH ₃ ) ₃ , - C (CH ₃ ) ₃ ;

a is a number between 0 and 3, in particular 0;

b stands for a number between 0 and 1, in particular 1,

m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,

R ^' is a monovalent radical selected from

-QN (R ") - CH ₂ -CH ₂ -N (R") ₂

-QN (R ¹¹ J ₂

-QN ⁺ (R ") ₃ A- -QN ⁺ H (R") ₂ A ^"

-QN ⁺ H ₂ (R ") A ^"

-QN (R ") - CH ₂ -CH ₂ -N ⁺ R" H ₂ A ^" ,

where each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₂ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, - CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₂ ) ₂ CH ₂ -,

R "is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the Ci. ₂₀ -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ J ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

 Cationic silicone oils, such as the commercially available Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone referred to as amodimethicone), Dow Corning 939, Dow Corning 949, Dow Corning 959, DC 2-2078 (manufactured by Dow Corning , INCI name: Aminopropyl Phenyl Trimethicone), DC 5-7113 (manufacturer Dow Corning, INCI name: Silicone Quaternium 16), SM-2059 (manufacturer: General Electric) and SLM-55067 (manufacturer: Wacker).

Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).

 Particular preference is also given to compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b)

contain, in which

R is -OH, an (optionally ethoxylated and / or propoxylated) (Ci to C ₂ o) -

Alkoxy group or a -CH ₃ group,

R 'is -OH, a (C ₁ to C ₂ o) alkoxy group or a -CH ₃ group and

m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2000, preferably between 50 and 150, the sum (n1 + n2) preferably having values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values of from 1 to 2000, in particular from 1 to 10.

 These silicones are according to the INCI declaration as Amodimethicone, or as functionalized Amodimethicone, such as bis (C13-15 alkoxy) PG Amodimethicone (for example, as a commercial product: DC 8500 from Dow Corning available), trideceth-9 PG-amodimethicones (for example as a commercial product Silcare Silicone SEA available from Clariant). Regardless of which amino-functional silicones are used, are

Cosmetic preparations according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g. The amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.

 In addition to the above-described amino-functional silicones may be preferred

amino-functional silicones can be used which are characterized by terminal amino groups, which in turn are particularly preferably quaternary. Excellent are here diquaternary silicones. Suitable diquaternary silicones are selected from compounds of the general formula (Si3c)

[R ¹ R ² R ³ N ⁺ -A- SiR ⁷ R ⁸ - (O-SiR ⁹ R ¹⁰ ) _n -O-SiR ¹¹ R ¹² -A-N ⁺ R ⁴ R ⁵ R ⁶ ] 2X (Si 3c) where the radicals R 1 to R 6 independently of one another denote C 1 to C 22 -alkyl radicals which may contain hydroxyl groups and where preferably at least one of the radicals has at least 8 C atoms and the remaining radicals have 1 to 4 C atoms,

the radicals R 7 to R 12, independently of one another, are identical or different and denote C 1 to C 10 -alkyl or phenyl,

 A represents a divalent organic linking group,

n is a number from 0 to 200, preferably from 10 to 120, particularly preferably from 10 to 40, and

X ^"is an anion.

 The divalent linking group is preferably a C1 to C12 alkylene or

Alkoxyalkylene group which may be substituted with one or more hydroxyl groups.

Particularly preferred is the group - (CI-I ₂ ) _S -O-CI-I ₂ -CI-I (OI-I) -CI-I ₂ -.

The anion X ^" can be a halide ion, an acetate, an organic carboxylate or a

Compound of the general formula RSO ₃ ^' , wherein R has the meaning of C1 to C4 alkyl radicals.

 A preferred diquaternary silicone has the general formula (Si3d)

[RN ⁺ Me ₂ -A- (SiMe ₂ O) _n -SiMe ₂ -A-N ⁺ Me ₂ R] 2 CH ₃ COO ^" (Si 3d),

where A is the group - (CH ₂ ) ₃ - O - CH ₂ - CH (OH) - CH ₂ -,

R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.

Suitable silicone polymers having two terminal quaternary ammonium groups are known under the INCI name Quaternium-80. These are dimethylsiloxanes with two terminal trialkylammonium groups. Such diquaternary polydimethylsiloxanes are marketed by Evonik under the trade names Abil ^® Quat 3270, 3272 and 3474th

 Only recently are completely new polyammonium polysiloxane compounds as

amino-functional silicones are known in which the siloxane substructures are optionally connected to each other via ammonium substructures. These polyammonium polysiloxane compounds may be obtained for example under the trade name Baysilone® ^® GE Bayer Silicones. The products named Baysilone TP 3911, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 391 1 as the active component of the compositions according to the invention.

Cosmetic or dermatological preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.1 to 15% by weight, preferably 0.1 to 10% by weight, particularly preferably 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of amino-functional silicone (s) and / or diquaternary silicone.

As further silicones, water-soluble silicones can be present in the compositions according to the invention. Particularly preferred dimethicone copolyols according to the invention are, for example, those sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW

CORNING (Dow) distributed products.

 Particularly preferred dimethicone copolyols according to the invention are Dow Corning 190 and Dow

Corning 193 (Dow).

 The Dimethiconcopolyole are in the compositions of the invention in amounts of

0.01 to 10 wt.%, Preferably 0.01 to 8 wt.%, Particularly preferably 0.1 to 7.5 wt.% And in particular 0.1 to 5 wt.% Of dimethicone copolyol based on the composition.

 Of course, the teaching of the invention also includes that a mixture of several

Ingredients b) from the different classes mentioned, at least two different classes can be used in the compositions according to the invention.

 According to the invention, the use of a mixture of silicone oils is preferred. This mixture of silicone oils preferably contains at least one dimethicone, which in turn also the

Cyclomethicones are to be expected. The dimethicones are particularly preferably selected from at least two different viscosity ranges. Thus, it has proved to be very advantageous according to the invention, if at least one low-viscosity dimethicone having a viscosity between 10 and 100 OcPs and at least one dimethicone with a

Viscosity can be used between 10,000 and 100,000 cps. It is most preferred if at least one cyclomethicone is further used with these two dimethicones.

Within the embodiment just described, it is further preferred if the

Dimethicones with the lower viscosity in relation to the dimethicones with the higher

Viscosity in a ratio of 25: 1 to 2: 1 based on the amounts used, stand.

A ratio of 20: 1 to 5: 1 is particularly preferred.

 The total amount of all silicone oils preferred according to the invention is at least 5.0 to 30.0

Wt.%. This means that if only one silicone according to the invention is used, this is contained with at least 5.0% by weight, based on the total composition. If several silicones according to the invention are used, the sum of the amounts of the individual silicones must be at least 5.0% by weight.

 Preferred embodiments of the invention comprise, in addition to a cosmetic carrier c) and the cationic copolymer a), the following ingredients b) as compulsory ingredients:

Embodiment 1:

 A dimethicone with a viscosity between 10 and 1000 cPs and a dimethicone with a

Viscosity of 10000 to 100000 cPs in a ratio of 25: 1 to 2: 1 (Dimethicone low viscosity: Dimethicone high viscosity) and in a total amount of silicone of at least 5.0 to at most 30.0 wt% in relation to the total composition.

 Embodiment 2:

In addition to Embodiment 1, at least 0.1 to 10.0 wt.% Of an amino-functional silicone is further contained. The total amount of silicone in the composition remains unchanged at at least 5.0 to at most 30.0 wt% in relation to the whole Composition. Of course, the abovementioned preferred ranges for the amino-functional silicone also apply, and in particular in this embodiment.

Embodiment 3:

 In contrast to embodiment 1, the low-viscosity dimethicone is partially a cyclomethicone. The low-viscosity dimethicone and the cyclomethicone are in a ratio of 2: 1 to 1: 2, preferably 1: 1. The further features of embodiment 1 apply here unchanged and are applied to the mixture of low-viscosity dimethicone and cyclomethicone.

Embodiment 4:

 Embodiment 4 substantially corresponds to Embodiment 2. Unlike Embodiment 2, as the low-viscosity dimethicone, a low-viscosity dimethicone and a cyclomethicone according to the provisos of Embodiment 3 are used.

 The present active ingredient combination according to the invention can be formulated as a rinse-off application or as a leave-on application. An application as a leave-on application is preferred. Within the leave-on applications, packaging as a non-aerosol spray is particularly preferred.

Furthermore, in a preferred embodiment of the active ingredient combination (A) according to the invention, cosmetic oils can be used. These oil bodies preferably have a melting point of less than 50 ^° C., more preferably less than 45 ^° C., very preferably less than 40 ^° C., most preferably less than 35 ^° C., and most preferably the cosmetic oils are at a temperature of less than 30 ^° C flowable. In the following, these oils are defined and described in more detail.

 The natural and synthetic cosmetic oils include, for example:

 vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.

liquid paraffin oils, isoparaffin oils and synthetic hydrocarbons and di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether Di-n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl-n Undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) - cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred.

Esteröle. Ester oils are to be understood as meaning the esters of C ₆ - C ₃₀ fatty acids with C ₂ - C ₃₀ fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred. Examples of fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures. Examples of the

Fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol,

Cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol, and technical mixtures thereof. According to the invention, particularly preferred are isopropyl myristate (IPM Rilanit ^®), isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), 2-ethylhexyl palmitate (Cegesoft ^® 24),

Stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, caprate Kokosfettalkohol- / caprylate (Cetiol ^® LC), n-butyl stearate, oleyl erucate (Cetiol ^® J 600), isopropyl palmitate (IPP Rilanit ^®), Oleyl Oleate (Cetiol ^®), hexyl laurate (Cetiol ^® A), di-n-butyl adipate (Cetiol ^® B), myristyl myristate (Cetiol ^® MM), Cetearyl Isononanoate (Cetiol ^® SN),

Decyl oleate (Cetiol ^® V).

 Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,

Propylene glycol di-pelargonate, butanediol di-isostearate, neopentyl glycol dicaprylate,

symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC),

Trifatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerol,

 Fatty acid partial glycerides, which are monoglycerides, diglycerides and their technical

Mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides. The partial glycerides preferably follow the formula (D4-I),

CH ₂ O (CH ₂ CH ₂ O) _m R ¹

 I

CHO (CH ₂ CH ₂ O) _n R ² (D4-I)

 I

CH ₂ O (CH ₂ CH ₂ O) _q R ³ in the R ¹ , R ² and R ^{3 is} independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen. The sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25. Preferably, R ^{1 is} an acyl radical and R ² and R ^{3 are} hydrogen and the sum (m + n + q) is 0. Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic , Elaeo- Stearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures. Preferably, oleic acid monoglycerides are used.

Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, safflower oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.

 In many cases, the agents contain at least one surface-active substance, whereby in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances are suitable. The choice of surfactants depends on the nature of the agent. In the case of a shampoo, in particular at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen. These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants. The ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5. The ratio is particularly preferably 5: 1 to 1: 2. Suitable anionic surfactants (tanion) in preparations according to the invention are all suitable for use on the human body suitable anionic surfactants. The following anionic surfactants have proven to be mild to particularly mild and are particularly preferred according to the invention:

 lactylates,

 Hydroxymischethersulfate,

Ethercarbonsäuren the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear

 Alkyl group having 8 to 30 carbon atoms and x = 0 or 1 to 16 and their salts,

 Acylsarcosides having 8 to 24 carbon atoms in the acyl group,

 Acyltaurides having 8 to 24 carbon atoms in the acyl group,

 Acyl isethionates having 8 to 24 carbon atoms in the acyl group,

 Sulfobernsteinsäuremono- and -dialkylester having 8 to 24 carbon atoms in the alkyl group and

Sulfosuccinic acid mono-alkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups.

Alkylpolyglykolethersulfate of the formula RO (CH ₂ -CH ₂ O) _x -OSO ₃ H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x = 0 or 1 to 12,

 Esters of tartaric acid and citric acid with alcohols containing adducts of about 2-

15 molecules of ethylene oxide and / or propylene oxide to fatty alcohols having 8 to 22 carbon atoms, Alkyl and / or alkenyl ether phosphates of the formula

R ¹ (OCH ₂ CH ₂ ) _n -O- (PO-OX) -OR ² ,

in the R ^{1 is} preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R ^{2 is} hydrogen, a radical (CH ₂ CH ₂ O) _n R ² or X, n is from 1 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or NR ³ R ⁴ R ⁵ R ⁶ , where R ³ to R ⁶ independently of one another represent hydrogen or a C ¹ to C ₄ hydrocarbon radical,

 Monoglyceride sulfates and monoglyceride ether sulfates of the formula

ROC- (OCH ₂ CH ₂ ) _x -OCH ₂ - [CHO (CH ₂ CH ₂ O) _y H] -CH ₂ O (CH ₂ CH ₂ O) _z -SO ₃ X,

 in which RCO is a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z are in total 0 or numbers of 1 to 30, preferably 2 to 10, and X is an alkali or alkaline earth metal. Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and also their ethylene oxide adducts

 Sulfur trioxide or chlorosulfonic acid in the form of its sodium salts. Preferably, monoglyceride sulfates are used in which RCO is a linear acyl radical having 8 to 18 carbon atoms,

- Amidethercarbonsäuren, R ¹ -CO-NR ² -CH ₂ CH ₂ -O- (CH ₂ CH ₂ O) _n CH ₂ COOM, with R ¹ as

straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20 and R ² is hydrogen, a methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl radical and M is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR ³ R ⁴ R ⁵ R ⁶ , with R ³ to R ⁶ independently of one another represent hydrogen or a C ¹ to C ⁴ hydrocarbon radical. Such products are available, for example, by the company Chem Y under the product Akypo ^®.

 Condensation products of a water-soluble salt of a water-soluble

Protein hydrolysates with a suitable fatty acid derivative, for example a C8 - C30 fatty acid halide. Such products are available under the trademark Lamepon® ^®, Maypon ^®, Gluadin® ^®, Hostapon® ^® KCG or Amisoft ^® has long been in the trade,

 Acylglutamates and

 Aspartates.

Further, in the case of mild anionic surfactants having polyglycol ether units, it is preferable that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether groups with no restricted homolog distribution can be obtained, for example on the one hand the number of polyglycol ether groups is 4 to 12 and Zn or Mg ions are selected as counterion. Example is the commercial product Texapon.RTM ^® ASV.

Zwitterionic surfactants (tweets) are those surface-active compounds which in the molecule have at least one quaternary ammonium group and at least one -COO ⁽⁾ - or -SO ₃ ^ group wear. Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine. Ampholytic surfactants (tampho) are understood as meaning those surface-active compounds which contain, in addition to a C ₈ -C ₂₄ -alkyl or -acyl group, at least one free amino group and at least one -COOH or -SO ₃ H group in the molecule and for the formation of internal Salts are capable. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Typical examples of amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.

Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ -acylsarcosine.

Nonionic surfactants are for example

 Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide onto linear and branched fatty alcohols having 6 to 30 carbon atoms, the fatty alcohol polyglycol ethers or the fatty alcohol polypropyleneglycol ethers or mixed fatty alcohol polyethers,

 Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty acids having 6 to 30 carbon atoms, the fatty acid polyglycol ethers or the Fettsäurepolypropylenglykolether or mixed fatty acid polyethers,

 Addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched alkylphenols having 8 to 15 carbon atoms in the alkyl group, the

 Alkylphenolpolyglykolether or the Alkylpolypropylenglykolether, or mixed

 Alyklphenolpolyether,

with a methyl or C ₂ - C ₆ - alkyl radical end-capped addition products of 2 to 50 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear and branched fatty alcohols having 8 to 30 carbon atoms, to fatty acids having 8 to 30 carbon atoms and to alkylphenols having 8 to 15 C atoms in the alkyl group, such as those among the

Sales names Dehydrol® ^® LS, Dehydrol® ^® LT (Cognis) types,

C ₁₂ -C ₃₀ -fatty acid mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol,

Addition products of 5 to 60 mol ethylene oxide onto castor oil and hydrogenated castor oil, polyol fatty acid esters, such as the commercially available product ^® Hydagen HSP (Cognis) or Sovermol ^® - types (Cognis),

alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of the formula (Tnio-1)

R ¹ CO- (OCH ₂ CHR ² ) _W OR ³ (Tnio-1)

in the R ¹ CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R ^{2 is} hydrogen or methyl, R ^{3 is a} linear or branched alkyl radical having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,

Amine oxides,

 hydroxy mixed,

 Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,

 Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters,

Addition products of ethylene oxide to fatty acid alkanolamides and fatty amines,

Sugar surfactants of the alkyl and alkenyl oligoglycoside type of formula (E4-II),

in the R ^{4 is} an alkyl or alkenyl radical having 4 to 22 carbon atoms, G is a

Sugar residue with 5 or 6 carbon atoms and p stands for numbers from 1 to 10.

 Sugar surfactants of the fatty acid N-alkylpolyhydroxyalkylamide type, a nonionic surfactant of the formula (Tnio-3),

R ⁵ CO-NR ⁶ - [Z] (Tnio-3)

in the R ⁵ CO for an aliphatic acyl radical having 6 to 22 carbon atoms, R ⁶ for

Is hydrogen, an alkyl or hydroxyalkyl radical having 1 to 4 carbon atoms and [Z] is a linear or branched polyhydroxyalkyl radical having 3 to 12 carbon atoms and 3 to 10 hydroxyl groups.

A most preferred embodiment contains at least one cationic surfactant. Cationic surfactants (Tkat) are generally derived from ammonium ions and have a structure (NR ¹ R ² RV) ⁺ A ^" (Tkati)

with a correspondingly negatively charged counterion A.

In all cationic surfactants according to the invention, the anion A is selected from the physiologically acceptable anions. Illustrative of the anion are the halides, fluoride, chloride, bromide, iodide, phosphate, dihydrogen phosphate, hydrogen phosphate, hydrogen sulfate, sulfate (methosulfate) of the general formula RSO ₃ ^" in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, in particular methosulfate and ethosulfate, or anionic organic acid residues such as maleate, fumarate, oxalate, tartrate, citrate, lactate or acetate, particularly preferred cationic surfactants have as anion the chloride or methosulfate with a methyl or ethyl group as radical R.

Such cationic ammonium compounds of the formula (Tkati) are well known to the person skilled in the art. The radicals R 1 to R 4 may each independently of one another denote straight-chain, branched, cyclic, aromatic saturated or unsaturated alkyl and / or alkenyl chains having at least 1 to 30 carbon atoms, hydrogen, -OH or hydroxyethyl.

Cationic structures in which the radicals R 1, R 2 and R 3 in each case denote a methyl group and R 4 represents a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms and furthermore the radical are preferred according to the invention R4 represents a saturated, branched or unbranched alkyl radical, more preferably unbranched alkyl radical having a chain length of 18 to 24, most preferably having a chain length of 22 to 24 carbon atoms. Preferred quaternary ammonium compounds of the structure (Tkati) are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, for example, distearyldimethylammonium chloride, Lauryldimethylammo- niumchlorid, lauryldimethylbenzylammonium chloride and tricetylmethyl ammonium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium bromide and behenyl trimethyl ammonium methosulfate , Preference is given to cetyltrimethylammonium and behenyltrimethylammonium salts. Particularly preferred are the latter in the form of methosulfates and bromides. Most preferred are cetyltrimethylammonium methosulfate and behenyltrimethylammonium methosulfate and most preferred is behenyltrimethylammonium methosulfate.

 Furthermore, in one embodiment, esterquats according to the formula (Tkat1-2) can be used.

 (Tkati -2)

 Here, the radicals R1, R2 and R3 are each independently and may be the same or different. The radicals R1, R2 and R3 mean:

 a branched or unbranched alkyl radical having 1 to 4 carbon atoms which may contain at least one hydroxyl group, for example methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, hydroxyethyl, hydroxymethyl, or

 a saturated or unsaturated, branched or unbranched or a cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxyl group, or

 an aryl or alkaryl radical, for example phenyl or benzyl,

 the rest (- A - R4), with the proviso that at most 2 of the radicals R1, R2 or R3 can stand for this radical:

 The remainder - (A - R4) is contained at least 1 to 3 times.

Herein A stands for:

 1) - (CH 2) n - with n = 1 to 20, preferably n = 1 to 10 and particularly preferably n = 1 - 5, or

 2) - (CH 2 -CHR 5 -O) n - where n = 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl,

and R4 stands for: 1) R6-0-C0-, wherein R6 is a saturated or unsaturated, branched or

 is unbranched or a cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which may optionally be further ethoxylated with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units, or

 2) R7-CO-, wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30

 Carbon atoms which may contain at least one hydroxy group, and which may optionally be further ethoxylated with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units,

and Q is a physiologically acceptable organic or inorganic anion which has been described as previously under formula (Tkati). Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are marketed under the trademarks Rewoquat ^®, Stepantex® ^{®, ®} and Dehyquart® Armocare® ^®. The products Armocare ^® VGH- 70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80, Dehyquart ^® F-30, Dehyquart ^® AU 35, Rewoquat ^® WE18, Rewoquat WE38 ^® DPG and Stepantex ^® GS 90 are examples of such esterquats.

(Tkati -2.1 ) Further compounds of the formula (Tkati-2) which are particularly preferred according to the invention belong to the formula (Tkat1-2.1), the cationic betaine esters.

(Tkati -2.1)

R8 corresponds in its meaning R7.

Further preferred cationic surfactants are cationic surfactants of the formula (Tkat-2).

 R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain,

X is - O - or - NR ⁵ -,

R ¹ represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution,

R ² and R ³ each independently represent an alkyl or hydroxyalkyl group having 1 to 6 C atoms in the chain, which chain may be straight or branched. Examples of radicals according to the invention are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, iso-hexyl, hydroxyalkyl, dihydroxyalkyl, hydroxyethyl, Hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl,

 R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxyl group, especially methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, iso-pentyl, neo-pentyl, hexyl, iso -hexyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl and

A ^' denotes an anion as already described in the formula (Tkati).

 Within this structural class, the compounds of one of the following structures are preferably used:

CH ₃ (CH ₂ ) ₂ oCONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ CH ₃ A ^" (Tkat-3)

CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ (CHOH) CH ₂ OH A ^" (Tkat-4)

CH ₃ (CH 2) ₂₀ COOCH ₂ CHOHCH ₂ - N ⁺ (CH ₃ ) ₃ A ^" (Tkat-5)

CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ CH ₂ OH A ^" (Tkat-6)

Examples of such commercial products are Schercoquat BAS, Lexquat AMG-BEO, Akypoquat 131 or Incroquat Behenyl HE.

 In a particularly preferred embodiment of the invention, the compositions according to the invention furthermore comprise at least one amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas:

R ¹ --NH - (CH ₂ ) _n --NR ² R ³ (Tkat7) and / or

R ¹ --NH - (CH ₂ ) _n --NR ² R ³ R ⁴ (Tkatδ)

wherein R1 is an acyl or alkyl radical having 6 to 30 carbon atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical may contain at least one OH group, and

 R 2, R 3 and R 4 are each independently of one another hydrogen or an alkyl radical having 1 to 4 C atoms, which may be identical or different, saturated or unsaturated, and

n is an integer between 1 and 10.

 The anion is in turn selected from the physiologically acceptable anions as already described in the formula (Tkati).

Preference is given to a composition in which the amine and / or the quaternized amine according to general formulas (Tkat7) and / or (Tkatδ) is an amidoamine and / or a quaternized amidoamine, in which R1 is a branched or unbranched, saturated or unsaturated acyl radical with 6 to 30 carbon atoms, which may contain at least one OH group means. Preference is given in this case to a fatty acid radical of oils and waxes, in particular of natural oils and waxes. Examples of these are lanolin, bees or candellila waxes. Also preferred are those amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkatδ) represent a radical according to the general formula CH ₂ CH ₂ OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen. The preferred size of n in the general formulas (Tkat7) and / or (Tkatδ) is an integer between 2 and 5. Also preferred are amidoamines and / or quaternized amidoamines of the general formulas (Tkat7) and / or (Tkatδ) in which the anion is a halide ion or a compound of the general formula RSO ₃ ^' , where R is the meaning of saturated or unsaturated alkyl radicals with 1 has up to 4 carbon atoms.

 The alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.

Suitable amidoamines to be used according to the invention, which may optionally be quaternized, are, for example, amidoamines: Witcamine 100 (Witco, INCI name: Cocamidopropyl Dimethylamine), Incromine BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackin 401 (McIntyre, INCI name: isostearylamidopropyl dimethylamine) and other Mackine types, Adogen S18V (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat RTM 50 (Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat UTM 50 (Witco Surfactants GmbH, Undecyleneamidopropyltrimonium Methosulfate).

Finally, as cationic surfactants, quaternary imidazoline compounds, i. Compounds having a positively charged imidazoline ring can be used. The formula (Tkat9) shown below shows the structure of these compounds.

The radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30

Carbon atoms. The preferred compounds of formula (Tkat9) for R each contain the same hydrocarbon radical. The radicals R are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 18 carbon atoms. The preferred compounds of the formula I each contain the same hydrocarbon radical for R. The chain length of the radicals R is preferably 12 to 18 carbon atoms. Particularly preferred are compounds having a chain length of at least 16 carbon atoms and most preferably having 18 carbon atoms. The chain length of the radicals R is most preferably at least 20 carbon atoms. Most preferred are compounds having a chain length of at least 21 carbon atoms. Preferred radicals R are cetyl, oleyl, palmityl, stearyl and behenyl. A is a physiologically acceptable anion, as already described for the cationic compounds of the formula (Tkati). Especially examples of the invention are available under the INCII names Quaternium-27, Quaternium-72 and Quaternium-83. A supreme preferred commercial product of this chain length is known for example under the name Quaternium-91.

 Of course, the teaching of the invention also includes that at least two cationic surfactants are used. In this case it is preferred if the cationic surfactants are selected from two different structural classes.

 The cationic surfactants are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight , The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

 Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.

 The surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,

Emulsifiers which can be used according to the invention are, for example

Ethercarbonsäuren the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear

 Alkyl group having 8 to 30 C atoms and x = 0 or 1 to 16,

 Acylsarcosides having 8 to 24 carbon atoms in the acyl group,

 Acyltaurides having 8 to 24 carbon atoms in the acyl group,

 Acyl isethionates having 8 to 24 carbon atoms in the acyl group

 Sulfobernsteinsäuremono- and -dialkylester having 8 to 24 carbon atoms in the alkyl group and

Sulfosuccinic acid mono-alkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,

 Esters of tartaric acid and citric acid with alcohols containing adducts of about 2-

15 molecules of ethylene oxide and / or propylene oxide to fatty alcohols having 8 to 22 carbon atoms,

 Alkyl and / or alkenyl ether phosphates as already described for the surfactants,

 Monoglyceride sulfates and monoglyceride ether sulfates as already described for the surfactants,

Amide ether carboxylic acids as described in the chapter on surfactants,

 Condensation products of a water-soluble salt of a water-soluble

 Protein hydrolyzate fatty acid condensation product,

 Zwitterionic surfactants (tweets)),

 Ampholytic surfactants (Tampho),

 Sugar surfactants of the alkyl or alkenyl oligoglycoside type,

 Sugar surfactants of the fatty acid N-alkyl polyhydroxyalkylamide type,

 Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,

Polyol fatty acid esters, such as the commercial product Hydagen ^® HSP (Cognis) or

Sovermol ^® - types (Cognis)

Amine oxides, Hydroxymix ethers, for example of the formula

R ¹ O [CH ₂ CH (CH ₃ ) O] _X (CH ₂ CHR ² O) _X [CH ₂ CH (OH) R ³ I _Z with R ^{1 being} a linear or branched, saturated or unsaturated alkyl and / or or alkenyl radical having 2 to 30 C atoms, R ^{2 is} hydrogen, a methyl, ethyl, propyl or iso - propyl radical, R ^{3 is} a linear or branched alkyl radical having 2 to 30 C atoms, x is 0 or a number from 1 to 20, Y stands for a number from 1 to 30 and z stands for the number 1, 2, 3, 4 or 5.

 Sorbitan fatty acid esters and adducts of ethylene oxide with sorbitan fatty acid esters such as the polysorbates,

 Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters, addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines,

 Sugar surfactants of the alkyl and alkenyl oligoglycoside type of formula (E4-II),

 esterquats

 Alkylamidoamines and quaternized alkylamidoamines.

C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, with degrees ofomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as sugar component being preferred,

Mixtures of alkyl (oligo) glucosides and fatty alcohols, for example, the commercially available product ^® Montanov 68,

 Addition products of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil, partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 carbon atoms,

 sterols,

 Phospholipids. Of these, especially the glucose phospholipids, e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.

 Fatty acid esters of sugars and sugar alcohols, such as sorbitol,

Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH),

 Very particularly cationic and / or amphoteric and / or zwitterionic polymers are used as further ingredients in the compositions according to the invention.

In the following some examples of particularly preferred polymers are described. The cationic polymers may be homo- or copolymers, the quaternary

Nitrogen groups are contained either in the polymer chain or preferably as a substituent on one or more of the monomers. The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers, for example trialkylmethacryloxyalkylammonium, trialkylacryloxyalkylammonium,

Dialkyldiallylammonium and quaternary vinylammonium monomers with cyclic, cationic Nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, for example alkylvinylimidazolium, alkylvinylpyridinium, or Alyklvinylpyrrolidon salts. The alkyl groups of these monomers are preferably lower alkyl groups such as C1 to Cl alkyl groups, more preferably C1 to C3 alkyl groups.

 The ammonium group-containing monomers may be copolymerized with non-cationic monomers. Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.

Suitable polymers having quaternary amine groups are, for example, the polymers described in the CTFA Cosmetic Ingredient Dictionary under the names Polyquaternium, such as methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Polyquaternium-16) or

quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11). Among the cationic polymers that can be included in the inventive composition, for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ^® 755 N and Gafquat ^® 734, United States is marketed by Gaf Co. and of which the Gafquat ^® 734 is particularly preferred suitable. Other cationic polymers are, for example, Germany, marketed by the company BASF under the tradename Luviquat ^® HM 550 copolymer of polyvinyl pyrrolidone and imidazolimine which ^® by the company Calgon / USA under the trade name Merquat Plus 3300 sold terpolymer of dimethyldiallylammonium chloride, sodium acrylate and acrylamide and sold by the company ISP under the trade name Gafquat ^® HS 100 vinylpyrrolidone / methacrylamidopropyltrimethylammonium chloride copolymer.

A particularly suitable homopolymer is the optionally crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium 37. Such products are, for example, under the names Rheocare ^® CTH (Cosmetic Rheologies) and Synthalen ^® CR (3V Sigma) are commercially available. 50% polymer content, further components: mineral oil (INCI name: Mineral OiI) and tridecyl-polyoxypropylene-polyoxyethylene ether (INCI name: PPG-1-trideceth-6) are further polymer dispersions under the names Salcare ^® SC 95 ) and Salcare ^® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available.

A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ^® SC. Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example, cationic derivatives of cellulose, starch or guar. Also suitable are chitosan and chitosan derivatives.

A cationic cellulose is sold under the name Polymer JR 400 from Amerchol ^® and has the INCI designation Polyquaternium-10 degrees. Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol. Other commercial products are the compounds Celquat ^® H 100, Celquat ^® L and 200. The commercial products mentioned are preferred cationic celluloses.

Suitable cationic guar derivatives are marketed under the trade name Jaguar ^® and have the INCI name guar hydroxypropyltrimonium chloride. Further particularly suitable cationic guar derivatives are also used by the company. Hercules under the name N-Hance ^® commercially. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ^®. A preferred cationic guar derivative is the commercial product AquaCat® ^® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.

A suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ^®. A preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ^® PC by Amerchol, USA. Further chitosan derivatives are Hydagen® ^® CMF, Hydagen® ^® HCMF and Chitolam ^® NB / 101 freely available under the trade names in the trade.

 Further preferred cationic polymers are, for example

 cationic alkyl polyglycosides,

cationized honey, for example the commercial product Honeyquat ^® 50,

polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid. The under the names Merquat ^® 100

(Poly (dimethyldiallylammonium chloride)) and Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) are examples of such cationic polymers,

Vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ^® FC 370, FC 550, FC 905 and HM 552,

 quaternized polyvinyl alcohol,

 and the polymers known under the names Polyquaternium-2, Polyquaternium-17, Polyquaternium-18 and Polyquaternium-27 with quaternary nitrogen atoms in the polymer main chain,

 Vinylpyrrolidone-Vinylcaprolactam-acrylate terpolymers, such as those with acrylic acid esters and acrylamides as a third monomer building commercially, for example, under the

Designation Aquaflex ^® SF 40 are offered. , Gaffix ^® VC 713 (manufactured by ISP): Also according to the invention can be used the copolymers of vinylpyrrolidone, such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ^® ASCP 1011, Gafquat ^® HS 110, Luviquat ^® 8155 and Luviquat ^® MS 370 available are. Furthermore, cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates. As typical examples of the cationic protein hydrolysates and derivatives according to the invention, those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 ^th Street, NW, Suite 300 Washington, DC 20036-4702) and commercially available products.

The cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

Amphoteric polymers, like the cationic polymers, are most preferred polymers. Particularly preferred amphoteric polymers are copolymers of diallyl dimethyl ammonium chloride and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-22, among others, with the trade name Merquat ^® 280 (Nalco). Very particularly preferably used according to the invention amphoteric polymers are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are marketed ^® under the INCI name Polyquaternium-39, among others, with the trade name Merquat Plus 3330 (Nalco).

 The amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

 The anionic polymers are anionic polymers which have carboxylate and / or sulfonate groups. Examples of anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.

Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt , More preferably, the homopolymer of 2-acrylamido-2-methylpropansulfon acid, which is commercially available, for example under the name Rheothik ^® 11- 80.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group wholly or partly as Sodium, potassium, ammonium, mono- or triethanolammonium salt is present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C ₁₃ -C ₄ -lsoparaffin) and a non-ionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention.

Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, in particular those with crosslinks, are also dye-retaining polymers. A 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name ^® Stabileze QM. The anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

Suitable nonionic polymers are, for example:

Vinylpyrrolidone / vinyl ester copolymers, as sold, for example, under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each

Vinyl pyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers. Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy- as for example under the trademark Culminal® ^® and

Benecel ^® (Aqualon) and Natrosol ^® grades (Hercules) are sold.

Starch and its derivatives, in particular starch, such as Structure XL ^®

 (National Starch), a multifunctional, salt-tolerant starch;

 shellac

Polyvinylpyrrolidones, as sold for example under the name Luviskol ^® (BASF).

 The nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.

 The polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition.

Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.

With particular preference the compositions according to the invention contain fatty substances (fat) as further active ingredient. By fatty substances (fat) are meant fatty acids, fatty alcohols, natural and synthetic waxes, which may be both in solid form and liquid in aqueous dispersion, and to understand natural and synthetic cosmetic oil components.

As fatty acids (Fatac) can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ^® 871 and Emersol ^® 875, and isopalmitic acids such as the commercial product Edenor ^® IP 95, and all other products sold under the trade names Edenor ^® (Cognis) fatty acids. Further typical examples of such fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and their technical mixtures.

 The amount used is 0.1 - 15 wt.%, Based on the total mean. The amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.

Fatty alcohols (Fatal) may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C ₆ - C ₃₀ -, preferably C ₁₀ - C ₂₂ - and particularly preferably C ₂ - C ₂₂ - carbon atoms. Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character. The fatty alcohols may be a mixture of different fatty alcohols. Such substances are, for example, under the names Stenol ^® such as Stenol ^® 1618 or Lanette ^® such as Lanette ^® O or Lorol ^®, for example, Lorol ^® C8, Lorol C14 ^®, Lorol C18 ^{®, ®} Lorol C8-18, HD-Ocenol ^®, Crodacol ^® such as Crodacol ^® CS, Novol ^®, Eutanol ^® G, Guerbitol ^® 16, Guerbitol ^® 18, Guerbitol ^® 20, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb ^® 12, Isocarb ^® 16 or acquire Isocarb® ^® 24 for sale. Of course, wool wax alcohols, as are commercially available, for example under the names of Corona ^®, White Swan ^®, Coronet ^® or Fluilan ^® can be used according to the invention. The fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.

As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention. Such waxes are available, for example, from Kahl & Co., Trittau.

The amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent. The total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.

 Another inventive synergistic active ingredient in the compositions according to the invention with the active ingredient complex according to the invention are protein hydrolysates and / or derivatives thereof (P).

 According to the invention, protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.

Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts. Such products are, for example, under the trademarks Dehylan ^® (Cognis), Promois® ^® (Interorgana) Collapuron ^® (Cognis), Nutrilan® ^® (Cognis), Gelita-Sol ^® (German Gelatinefabriken Stoess & Co), Lexein ^® (Inolex) and kerasol tm ^® (Croda) sold.

Further preferred vegetable protein hydrolysates according to the invention are, for example, soya, almond, pea, potato and wheat protein hydrolysates. Such products are, for example, under the trademarks Gluadin ^® (Cognis), diamine ^® (Diamalt) ^® (Inolex), Hydrosoy ^® (Croda), hydro Lupine ^® (Croda), hydro Sesame ^® (Croda), Hydro tritium ^® (Croda) and Crotein ^® (Croda) available.

Further preferred protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates. Examples of pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ^® or Crodarom ^® Pearl.

 The protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.

The effect of the compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C ₁ - to C ₄ -alkyl groups. The sodium salt is most preferred. The amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.

 Another preferred group of ingredients of the compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors. Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The ß-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate in Consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

The vitamin B group or the vitamin B complex include u. a.

Vitamin B ₁ (thiamine)

Vitamin B ₂ (riboflavin)

Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.

Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the

Panthenol triacetate, the panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are in the

 Agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.

Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

 Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.

 Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

 Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed. Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.

The compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.

Finally, the use of plant extracts (L) in the compositions according to the invention gives rise to further advantages. The extracts of green tea, oak bark, stinging nettle, witch hazel, hops, henna, chamomile, burdock root, horsetail, hawthorn, lime blossom, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime , Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Valerian, Meadowfoam, Quercus, yarrow, thyme, lemon balm, toadstool, coltsfoot, marshmallow, meristem, ginseng, coffee, cocoa, moringa and ginger root are preferred. According to the invention, it may be highly preferred if so-called Ayurvedic plant extracts are used as plant extracts. Traditional Ayurvedic plants include Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica officinalis (Amalki), Morida Citrifolia (Ashyuka), Tinospora Cordifolia (Guduchi), Santalum album, (Chandana), Crocus sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).

 As a further essential ingredient, the agents according to the invention may contain purine and / or derivative (s) of purine. Preferred compositions of the invention contain purine and / or purine derivatives in narrower ranges. Here, preferred cosmetic compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s). Among purine, the purines and the purine derivatives, the following compounds are preferred according to the invention: purine, adenine, guanine, uric acid, hypoxanthine, 6-purinethiol, 6-thioguanine, xanthine, caffeine, theobromine and theophylline. In hair cosmetic formulations has become

In particular, caffeine proven useful, for example, in shampoos, conditioners, hair lotions and / or lotions preferably in amounts of 0.005 to 0.25 wt .-%, more preferably from 0.01 to 0.1 wt .-% and in particular of 0.01 to 0.05 wt .-% (in each case based on the composition) can be used.

 Another preferred active ingredient for additional use in the compositions of the invention is taurine and / or a derivative of taurine. Taurine is understood to mean exclusively 2-aminoethanesulfonic acid and explicitly mentioned derivatives of taurine. Taurine derivatives are understood as meaning N-monomethyltaurine and N, N-dimethyltaurine. Other taurine derivatives also include taurines, which naturally occur as metabolites in plant and / or animal and / or marine organisms. These include, for example, although not preferred, degradation products of cysteine, especially cysteine sulfinic acid. Further taurine derivatives for the purposes of the present invention are taurocholic acid and hypotaurine.

 Particularly preferred are agents according to the invention, which - based on their weight - 0.0001 to 10.0 wt .-%, preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and In particular, 0.001 to 1, 0 wt .-% taurine and / or a derivative of taurine included. In addition, it may prove advantageous if the compositions according to the invention contain penetration aids and / or swelling agents (M). These include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol, 1 , 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.

A particularly preferred group of swelling agents may be hydantoins. invention Compositions preferably contain 0.01 to 5 wt .-% hydantoin or at least one Hydatoinderivates. Hydantoin derivatives are particularly preferably used according to the invention, with 5-ureidohydantoin being particularly preferred. Regardless of whether hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably. The use according to the invention of polyhydroxy compounds as active ingredient with the other components according to the invention may be particularly preferred. Polyhydroxy compounds are understood as meaning organic compounds having at least two hydroxyl groups. In particular, for the purposes of the present invention, this is to be understood as meaning:

 Polyols having at least two hydroxyl groups, such as, for example, trimethylolpropane, carbohydrates, sugar alcohols and sugars, and salts thereof,

 in particular monosaccharides, disaccharides, trisaccharides and oligosaccharides, which may also be in the form of aldoses, ketoses and / or lactoses,

 Aminodeoxysugars, deoxysugars, thiosugars, which may also be in the form of aldoses, ketoses and / or lactoses,

 Very particularly preferred among these are monosaccharides having 3 to 8 C atoms, such as, for example, trioses, tetroses, pentoses, hexoses, heptoses and octoses, these also being able to be present in the form of aldoses, ketoses and / or lactoses.

 Furthermore, preferred are oligosaccharides having up to 50 monomer units. Examples of the polyols according to the invention include sorbitol, inositol, mannitol, tetrite, pentite, hexite, threitol, erythritol, adonite, arabitol, xylitol, dulcitol, erythrose, threose, arabinose, ribose, xylose, lyxose, glucose, galactose, mannose, allose , Altrose, gulose, idose, talose, fructose, sorbose, psicose, tegatose, deoxyribose, glucosamine, galactosamine, rhamnose, digitoxose, thioglucose, sucrose, lactose, trehalose, maltose, cellobiose, melibiose, gestiobiose, rutinose, raffinose and cellotriose.

 Preferred polyhydroxy compounds are sorbitol, inositol, mannitol, threitol, erythrose, erythrose, threose, arabinose, ribose, xylose, glucose, galactose, mannose, allose, fructose, sorbose, deoxyribose, glucosamine, galactosamine, sucrose, lactose, trehalose, maltose and cellobiose , Particular preference is given to using glucose, galactose, mannose, fructose, deoxyribose, glucosamine, sucrose, lactose, maltose and cellobiose. However, the use of glucose, galactose, mannose, fructose, sucrose, lactose, maltose or cellobiose is very particularly preferred

 Among the polyhydroxy compounds having 3 OH groups, glycerin is of outstanding importance.

 Irrespective of the type of polyhydroxy compound having at least 2 OH groups used, agents according to the invention are preferred which, based on the weight of the composition, contain 0.01 to 5 wt.%, Preferably 0.05 to 4 wt.%, Particularly preferably 0.05 to 3.5% by weight and in particular 0.1 to 2.5% by weight of polyhydroxy compound (s).

Very particularly preferred polyols of the present invention are polyols having 2 to 12 C atoms in the molecular skeleton. These polyols can be straight-chain, branched, cyclic and / or be unsaturated. The hydroxyl groups are very particularly preferably terminally adjacent or terminally separated from one another by the remainder of the chain. Examples of these polyols are: glycol, polyethylene glycol up to a molecular weight of up to 1000 daltons, neopentyl glycol, partial glycerol ethers having a molecular weight of up to 1000 daltons, 1,2-propanediol, 1,3-propanediol, glycerol, 1,2-butanediol , 1, 3-butanediol, 1, 4-butanediol, 1, 2,3-butanetriol, 1, 2,4-butanetriol, pentanediols, for example 1, 2-pentanediol, 1, 5-pentanediol, hexanediols, 1, 2- Hexanediol, 1,6-hexanediol, 1, 2,6-hexanetriol, 1,4-cyclohexanediol, 1,2-cyclohexanediol, heptanediols, 1,2-heptanediol, 1,7-heptanediol, octanediols, 1, 2-octanediol, 1, 8-octanediol, 2-ethyl-1, 3-hexanediol, octadienols, decadienols, dodecanediols, 1, 2-dodecanediol, 1, 12-dodecanediol, 1, 12-dodecanediol with 10 moles of EO, dodecadienols.

 The polyhydroxy compounds according to the invention are present in the compositions in concentrations of 0.01% by weight up to 20% by weight, preferably from 0.05% by weight up to 15% by weight and very particularly preferably in amounts of 0.1% by weight. up to 10% by weight. In a further embodiment, the agents according to the invention should additionally contain at least one UV light protection filter. By UV light protection filters are meant organic substances capable of absorbing ultraviolet rays and absorbing the absorbed energy in the form of longer wavelength radiation, e.g. Heat again. UVB filters can be oil-soluble or water-soluble.

 Furthermore, the cosmetic agents may contain other active ingredients, auxiliaries and additives, such as

 Structurants such as maleic acid and lactic acid,

 Perfume oils, dimethylisosorbide and cyclodextrins,

 Dyes for staining the agent,

 Anti-dandruff agents such as Piroctone Olamine, Zinc Omadine and Climbazole,

 Cholesterol,

 Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,

 Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers

 Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,

 pigments

 Stabilizing agent for hydrogen peroxide and other oxidizing agents,

Propellants such as propane-butane mixtures, N ₂ O, dimethyl ether, CO ₂ and air,

 Antioxidants.

 With regard to further optional components and the amounts of these components used, reference is expressly made to the relevant manuals known to the person skilled in the art.

 As already mentioned, the high care effect of the agents according to the invention is of particular importance, in particular, since it gives excellent results even in the presence of oxidizing agents, for example in the context of oxidative hair dyeing.

A second subject of the invention is therefore a method for hair treatment, in which a cosmetic composition according to claim 1 is applied to the hair and rinsed after a contact time of the hair. The exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.

 The following examples are intended to illustrate the subject matter of the present invention without, however, limiting it.

 A third subject of the invention is a method of hair treatment in which a cosmetic

Agent according to claim 1 is applied to the hair and on the hair until the next

Hair wash stays there.

 A fourth subject of the invention is that the cosmetic composition as a non-aerosol

Spray is present and applied to the hair and remains there until the next hair wash.

Examples

All quantities are, unless otherwise stated, parts by weight. Non aerosol spray conditioner

D-panthenol (75%) 0.2

 Lactic acid (80%) 0.35

 Methylparaben sodium salt 0.3

 Phenoxyethanol 0.4

 Dow Corning 959 0.2

 Dow Corning 200 Fluid 5 cS 10.0

 Dow Corning 200 Fluid 60000 cSt 0.5

TINOVIS ^® CD 1.7

 Perfume 0.35

 Water, demineralized ad 100

Claims

claims: 1. hair conditioning agent containing  a) a cationic copolymer consisting of a monomer of the formula (I) and a monomer of the formula (II) and  b) at least 5.0% by weight of at least one silicone oil, and  c) a cosmetic carrier.  2. Composition according to claim 1, characterized in that it, at least one silicone oil  selected from the group of dimethicones and the group of amodimethicones. 3. Composition according to one of claims 1 or 2, characterized in that it comprises at least one dimethicone having a viscosity between 10 and 100OcPs and at least one  Dimethicone having a viscosity between 10,000 and 100,000 cps.  4. Composition according to one of claims 1 to 3, characterized in that the or  Lower viscosity dimethicones relative to the higher viscosity dimethicone (s) in a ratio of from 25: 1 to 2: 1 based on the amounts used.  5. Composition according to one of claims 1 to 4, characterized in that the means  contains at least one amino-functional silicone oil.  6. Composition according to one of claims 1 to 5, characterized in that it additionally contains at least one substance from the group of vitamins, provitamins and vitamin precursors and their derivatives, with vitamins, pro-vitamins and vitamin precursors are preferred, the groups A, B, C, E, F and H are assigned.  7. Use of a preparation according to one of claims 1 to 6 for the conditioning of hair.  8. A method for the treatment of hair, wherein a preparation according to one of  Claims 1 to 6 is applied to the hair and remains there until the next hair wash.